Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 243,194 | 216,612 | 184,644 | 145,401 | 114,095 |
| Depreciation Amortization | 25,471 | 22,917 | 23,303 | 23,113 | 23,818 |
| Income taxes - deferred | 6,790 | 3,605 | -6,549 | -10,135 | 25,636 |
| Accounts receivable | -16,312 | -16,664 | -12,082 | -22,412 | 9,990 |
| Accounts payable and accrued liabilities | -6,339 | -3,672 | 11,969 | 11,701 | -8,579 |
| Other Working Capital | 6,551 | -23,419 | -21,024 | 22,188 | -1,977 |
| Other Operating Activity | 38,782 | 37,823 | 23,865 | 35,976 | 18,890 |
| Operating Cash Flow | $298,137 | $237,202 | $204,126 | $205,832 | $181,873 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -34,380 | -30,484 | -29,027 | -26,900 | -16,705 |
| Net Acquisitions | N/A | -556 | -18,821 | -9,000 | N/A |
| Purchase Of Investment | -98 | -322 | N/A | 0 | N/A |
| Purchase Sale Intangibles | -3,530 | -1,648 | -220 | -233 | -240 |
| Other Investing Activity | -8,720 | -2,642 | -4,170 | -2,837 | -1,835 |
| Investing Cash Flow | $-43,198 | $-34,004 | $-52,018 | $-38,737 | $-18,540 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 167,000 | 121,000 | 417,426 | 0 | 0 |
| Debt Repayment | -134,046 | -112,346 | -348,564 | -82,251 | 0 |
| Common Stock Issued | 83 | 5 | -219,154 | 346 | 408 |
| Common Stock Repurchased | -227,216 | -175,732 | -61,825 | -92,487 | -9,389 |
| Dividend Paid | -58,642 | -53,250 | -46,278 | -39,972 | -26,675 |
| Other Financing Activity | 3,744 | 7,019 | 1,739 | 104 | 17,230 |
| Financing Cash Flow | $-249,077 | $-213,304 | $-256,656 | $-214,260 | $-18,426 |
| Beginning Cash Position | 19,226 | 29,332 | 133,880 | 181,045 | 36,138 |
| End Cash Position | 25,088 | 19,226 | 29,332 | 133,880 | 181,045 |
| Net Cash Flow | $5,862 | $-10,106 | $-104,548 | $-47,165 | $144,907 |
| Free Cash Flow | |||||
| Operating Cash Flow | 298,137 | 237,202 | 204,126 | 205,832 | 181,873 |
| Capital Expenditure | -35,416 | -31,151 | -29,927 | -27,569 | -17,289 |
| Free Cash Flow | 262,721 | 206,051 | 174,199 | 178,263 | 164,584 |